Individual risk factors for venous thromboembolism (VTE) in cancer patients treated with targeted therapies (TT)

被引：0
|
作者：
Soini, B.
Caffo, O.
Ferro, A.
Ambrosini, G.
Murgia, V.
Valduga, F.
Caldara, A.
Eccher, C.
Tumulo, S.
Galligioni, E.
机构：
[1] Santa Chiara Hosp, Trento, Italy
[2] Fdn Bruno Kessler, Trento, Italy
[3] S Maria Angeli Hosp, Pordenone, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20549
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Incidence and risk factors for venous thromboembolism in gynecological cancer: the GOTIC-VTE trialIncidence and risk factors for venous thromboembolism in gynecological cancer: the GOTIC-VTE trialY. Takahashi et al.
    Yoshifumi Takahashi
    Hiroyuki Fujiwara
    Kouji Yamamoto
    Satoshi Yamaguchi
    Shoji Nagao
    Masashi Takano
    Morikazu Miyamoto
    Kosei Hasegawa
    Maiko Miwa
    Toshiaki Yasuoka
    Soichi Yamashita
    Takashi Hirakawa
    Tomonori Nagai
    Yoshinobu Hamada
    Masaya Uno
    Mayuyo Mori-Uchino
    Michitaka Ohwada
    Akira Mitsuhashi
    Toyomi Satoh
    Keiichi Fujiwara
    Mitsuaki Suzuki
    Journal of Thrombosis and Thrombolysis, 2025, 58 (2) : 299 - 308
  • [32] Venous Thromboembolism (VTE) in Patients with Hematologic and Non-Hematologic Malignancies: Incidence and Risk Factors for Recurrent VTE
    Vadhan-Raj, Saroj
    Zhou, Xiao
    Shah, Jatin J.
    Benjamin, Robert S.
    Gladish, Gregory
    BLOOD, 2011, 118 (21) : 999 - 999
  • [33] Risk Factors Associated with Venous Thromboembolism in Cancer Patients
    Lee, Su Jung
    Kim, Nam Cho
    ASIAN ONCOLOGY NURSING, 2015, 15 (03) : 171 - 177
  • [34] Anticoagulation and Bleeding Risk in Elderly Patients with venous Thromboembolism (VTE)
    Thomas, H. -P.
    ZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE, 2021, 54 (SUPPL 1): : S41 - S41
  • [35] Defining the Risk: Benefit Ratio of Venous Thromboembolism (VTE) Prophylaxis in Hospitalized Cancer Patients
    Angelini, Dana E.
    Greene, Todd
    Wietzke, Julie N.
    Flanders, Scott A.
    Sood, Suman L.
    BLOOD, 2015, 126 (23)
  • [36] Incidence and risk factors for venous thromboembolism, bleeding, and death in colorectal cancer (Cancer-VTE Registry)
    Ikeda, Masataka
    Uetake, Hiroyuki
    Yoshino, Takayuki
    Hata, Taishi
    Oba, Mari S.
    Takita, Atsushi
    Kimura, Tetsuya
    CANCER SCIENCE, 2022, 113 (11) : 3901 - 3911
  • [37] Prediction of Venous Thromboembolism (VTE) in Patients with Pancreatic Cancer Using Clinical Data, Biomarkers, and VTE Risk Models
    Ruch, Joshua M.
    Bellile, Emily
    Hawley, Angela E.
    Anderson, Michelle A.
    Wakefield, Thomas W.
    Sood, Suman L.
    BLOOD, 2012, 120 (21)
  • [38] Venous thromboembolism and cancer: Prevention of VTE
    Bergqvist, D
    THROMBOSIS RESEARCH, 2001, 102 (06) : V209 - V213
  • [39] Randomized Controlled Trial Of Dalteparin For Primary Thromboprophylaxis For Venous Thromboembolism (VTE) In Patients With Advanced Pancreatic Cancer (APC): Risk Factors Predictive Of VTE
    Raj, Saroj Vadhan
    Zhou, Xiao
    Varadhachary, Gauri R.
    Milind, Javle
    Fogelman, David
    Shroff, Rachna
    Ramos, Carlos E. Bueso
    Nguyen, Martin
    Wang, Xuemei
    Wolff, Robert A.
    Abbruzzese, James L.
    Overman, Michael J.
    BLOOD, 2013, 122 (21)
  • [40] Risk Factors for Inpatient Acute Venous Thromboembolism (VTE) Despite Thromboprophylaxis
    Wang, Tzu-Fei
    Wong, Catherine A.
    Milligan, Paul
    Thoelke, Mark S.
    Woeltje, Keith F.
    Gage, Brian F.
    BLOOD, 2012, 120 (21)
12345